<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03496064</url>
  </required_header>
  <id_info>
    <org_study_id>231/2014</org_study_id>
    <nct_id>NCT03496064</nct_id>
  </id_info>
  <brief_title>Registry for Evaluating Outcome of Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy.</brief_title>
  <acronym>BEYOND-SWIFT</acronym>
  <official_title>Bernese-European RegistrY for Ischemic Stroke Patients Treated Outside Current Guidelines With Neurothrombectomy Devices Using the SOLITAIRE™ FR With the Intention For Thrombectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Vall d'Hebron</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Bernese-European RegistrY for ischemic stroke patients treated Outside current guidelines
      with Neurothrombectomy Devices using the SOLITAIRE™ FR With the Intention For Thrombectomy
      (BEYOND-SWIFT) is a retrospective, multi-center, non-randomized observational study aims to
      investigate the safety and efficacy of a Medtronic market-released neurothrombectomy device
      (applied as initial devices used for intervention) in acute ischemic stroke patients who do
      not fulfill treatment eligibility according to current guidelines. Patients will be treated
      or were treated at the discretion of the investigator, independent of participation in this
      registry. Primary Analysis is the Impact of successful reperfusion on functional outcome at
      day 90 in patients presenting with large infarct cores (ASPECTS&lt;6) or minor symptoms
      (NIHSS&lt;8).
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">May 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">April 15, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>3 month functional independence</measure>
    <time_frame>0-90 days</time_frame>
    <description>Number of patients with modified Rankin Scale &lt;=2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Favourable outcome</measure>
    <time_frame>0-90 days</time_frame>
    <description>Number of patients with modified Rankin Scale &lt;=3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Excellent outcome</measure>
    <time_frame>0-90 days</time_frame>
    <description>Number of patients with modified Rankin Scale &lt;=1</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Successful reperfusion</measure>
    <time_frame>Day 0</time_frame>
    <description>Number of patients with modified Thrombolysis in Cerebral Infarction 2b / 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptomatic intracranial hemorrhage</measure>
    <time_frame>Day 0-1</time_frame>
    <description>Number of patients with symptomatic intracranial hemorrhage according to ECASSII definition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to reperfusion</measure>
    <time_frame>Day 0</time_frame>
    <description>Groin puncture to TICI2b/3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Day 0-90</time_frame>
    <description>Number of patients with modified Rankin Scale 6</description>
  </secondary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Anterior circulation LVO patients with ASPECTS &lt;6</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Anterior circulation LVO patients with NIHSS&lt;8</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Posterior versus anterior circulation LVO patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>LVO patients with isolated PCA or ACA occlusions</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Tandem lesions versus non-tandem lesion</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Bridging vs Direct MT</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Successful reperfusion</intervention_name>
    <description>Defined as modified Thrombolysis in Cerebral Infarction 2b/3</description>
    <arm_group_label>Anterior circulation LVO patients with ASPECTS &lt;6</arm_group_label>
    <arm_group_label>LVO patients with isolated PCA or ACA occlusions</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with large-vessel occlusion acute ischemic stroke subjected to endovascular
        treatment using a Medtronic market-released neurothrombectomy device (applied as initial
        devices used for intervention).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients or patient's legally authorized representative have given informed consent
             according to Good Clinical Practices (GCP) and/or IRB and/or local or institutional
             policies.

          -  The patient presents with an intracranial large vessel occlusion and therewith-related
             neurological symptoms and has been or will be treated with a Medtronic
             marketed-release neurothrombectomy device (applied as first device to attempt
             retrieving the thrombus).

        Exclusion Criteria:

          -  Current participation in another clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Urs Fischer, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology, University Hospital Bern, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jan Gralla, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neuroradiology, University Hospital Bern, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of Neurology, Bern University Hospital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2018</study_first_submitted>
  <study_first_submitted_qc>April 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2018</study_first_posted>
  <last_update_submitted>April 11, 2018</last_update_submitted>
  <last_update_submitted_qc>April 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Thrombectomy</keyword>
  <keyword>Eligibility</keyword>
  <keyword>Large vessel occlusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

